BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37983556)

  • 21. Kaempferol induces programmed cell death in Naegleria fowleri.
    Lê HG; Kang JM; Võ TC; Na BK
    Phytomedicine; 2023 Oct; 119():154994. PubMed ID: 37597363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Real-Time PCR Confirmation of a Fatal Case of Primary Amoebic Meningoencephalitis in Turkey Caused by Naegleria fowleri or Brain-Eating Amoeba.
    Oncel K; Karaagac L; Dagcı H; Aykur M
    Acta Parasitol; 2022 Jun; 67(2):697-704. PubMed ID: 35020127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential Growth Rates and
    Russell AC; Kyle DE
    Microbiol Spectr; 2022 Feb; 10(1):e0189921. PubMed ID: 35138140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of therapeutic chemical agents in vitro and on experimental meningoencephalitis due to Naegleria fowleri.
    Kim JH; Jung SY; Lee YJ; Song KJ; Kwon D; Kim K; Park S; Im KI; Shin HJ
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4010-6. PubMed ID: 18765686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naegleria fowleri: pathogenesis, diagnosis, and treatment options.
    Grace E; Asbill S; Virga K
    Antimicrob Agents Chemother; 2015 Nov; 59(11):6677-81. PubMed ID: 26259797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic effect of rokitamycin in vitro and on experimental meningoencephalitis due to Naegleria fowleri.
    Kim JH; Lee YJ; Sohn HJ; Song KJ; Kwon D; Kwon MH; Im KI; Shin HJ
    Int J Antimicrob Agents; 2008 Nov; 32(5):411-7. PubMed ID: 18762406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiamoebic activities of flavonoids against pathogenic free-living amoebae, Naegleria fowleri and Acanthamoeba species.
    Lê HG; Võ TC; Kang JM; Nguyễn TH; Hwang BS; Oh YT; Na BK
    Parasites Hosts Dis; 2023 Nov; 61(4):449-454. PubMed ID: 38043540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naegleria fowleri: Sources of infection, pathophysiology, diagnosis, and management; a review.
    Jahangeer M; Mahmood Z; Munir N; Waraich UE; Tahir IM; Akram M; Ali Shah SM; Zulfqar A; Zainab R
    Clin Exp Pharmacol Physiol; 2020 Feb; 47(2):199-212. PubMed ID: 31612525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and Evaluation of Benzylamine Inhibitors of Neuropathogenic
    Pomeroy JM; Khalifa MM; Milanes JE; Palmentiero CM; Morris JC; Golden JE
    ACS Med Chem Lett; 2024 Jan; 15(1):87-92. PubMed ID: 38229759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Environmental abiotic and biotic factors affecting the distribution and abundance of Naegleria fowleri.
    Stahl LM; Olson JB
    FEMS Microbiol Ecol; 2020 Dec; 97(1):. PubMed ID: 33242082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A local case of fulminant primary amoebic meningoencephalitis due to Naegleria fowleri.
    McLaughlin A; O'Gorman T
    Rural Remote Health; 2019 Apr; 19(2):4313. PubMed ID: 30961348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Naegleria fowleri proteins linked to primary amoebic meningoencephalitis.
    Jamerson M; Schmoyer JA; Park J; Marciano-Cabral F; Cabral GA
    Microbiology (Reading); 2017 Mar; 163(3):322-332. PubMed ID: 28086072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinically Approved Drugs against CNS Diseases as Potential Therapeutic Agents To Target Brain-Eating Amoebae.
    Anwar A; Rajendran K; Siddiqui R; Raza Shah M; Khan NA
    ACS Chem Neurosci; 2019 Jan; 10(1):658-666. PubMed ID: 30346711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The therapeutic potential of novel isobenzofuranones against Naegleria fowleri.
    Rizo-Liendo A; Arberas-Jiménez I; Sifaoui I; Gkolfi D; Santana Y; Cotos L; Tejedor D; García-Tellado F; Piñero JE; Lorenzo-Morales J
    Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():139-149. PubMed ID: 34627024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary Amoebic Meningoencephalitis by
    Güémez A; García E
    Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572533
    [No Abstract]   [Full Text] [Related]  

  • 36. Aryl Quinazolinone Derivatives as Novel Therapeutic Agents against Brain-Eating Amoebae.
    Mungroo MR; Shahbaz MS; Anwar A; Saad SM; Khan KM; Khan NA; Siddiqui R
    ACS Chem Neurosci; 2020 Aug; 11(16):2438-2449. PubMed ID: 31961126
    [No Abstract]   [Full Text] [Related]  

  • 37. Pathogenesis of amoebic encephalitis: Are the amoebae being credited to an 'inside job' done by the host immune response?
    Baig AM
    Acta Trop; 2015 Aug; 148():72-6. PubMed ID: 25930186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In Silico Structural Analysis of Serine Carboxypeptidase
    Madero-Ayala PA; Mares-Alejandre RE; Ramos-Ibarra MA
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293059
    [No Abstract]   [Full Text] [Related]  

  • 39. Primary Amoebic Meningoencephalitis: Potential Application of Ionic Liquids Against Brain-Eating Amoebae?
    Siddiqui R; Abouleish MY; Khamis M; Ibrahim T; Khan NA
    Acta Parasitol; 2022 Jun; 67(2):1032-1034. PubMed ID: 35294972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis of the primary amoebic meningoencephalitis due to Naegleria fowleri.
    Hara T; Fukuma T
    Parasitol Int; 2005 Dec; 54(4):219-21. PubMed ID: 16002330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.